Literature DB >> 19526316

Hepatocyte growth factor induced up-regulations of VEGF through Egr-1 in hepatocellular carcinoma cells.

Kyung Hee Lee1, Jae-Ryong Kim.   

Abstract

The potential role of hepatocyte growth factor (HGF) in the regulation of angiogenesis factors in hepatoma cells is not widely appreciated. We investigated the role of HGF-induced activation of a transcription factor, Egr-1, in the expression of pro-angiogenic factors. Genes associated with angiogenesis induced by HGF were screened by using cDNA microarray technology in hepatocellular carcinoma cell lines, HepG2 and Hep3B. Expression levels of Egr-1, vascular endothelial growth factor (VEGF), and interleukin (IL)-8 were further confirmed by real time RT-PCR and Western blot analysis. Roles of Egr-1 in the levels of HGF-induced up-regulations of VEGF and IL-8 were measured by knockdown of Egr-1 with Egr-1 shRNA and chromatin immunoprecipitation assay. The levels of Egr-1, VEGF and IL-8 were up-regulated in cells treated with HGF. HGF-induced up-regulations of Egr-1, VEGF, and IL-8 were inhibited by the pretreatment with an MEK inhibitor, PD098059. HGF-induced up-regulation of VEGF and IL-8 were repressed by Egr-1 knockdown. HGF enhanced the binding activity of Egr-1 to the VEGF promoter in control cells, but not in the Egr-1-shRNA cells. No constitutive and inducible Egr-1 binding activities to the IL-8 promoter were observed in control and Egr-1-shRNA cells. Egr-1 knockdown reduced the luciferase activities increased by HGF not in the IL-8 promoter, but in the VEGF promoter. Egr-1 might play an important role in the up-regulation of VEGF and IL-8 induced by HGF and contribute to HGF-mediated angiogenesis, which might be promising targets for hepatocellular carcinoma therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19526316     DOI: 10.1007/s10585-009-9266-7

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  27 in total

1.  Inducible PDGF A-chain transcription in smooth muscle cells is mediated by Egr-1 displacement of Sp1 and Sp3.

Authors:  E S Silverman; L M Khachigian; V Lindner; A J Williams; T Collins
Journal:  Am J Physiol       Date:  1997-09

Review 2.  Scatter factors and invasive growth.

Authors:  P M Comoglio; C Boccaccio
Journal:  Semin Cancer Biol       Date:  2001-04       Impact factor: 15.707

3.  Serum levels of vascular endothelial growth factor in patients with head and neck cancer.

Authors:  F Riedel; K Götte; J Schwalb; H Wirtz; W Bergler; K Hörmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2000       Impact factor: 2.503

4.  Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.

Authors:  Caren C Bancroft; Zhong Chen; Jason Yeh; John B Sunwoo; Ning T Yeh; Sadhana Jackson; Chad Jackson; Carter Van Waes
Journal:  Int J Cancer       Date:  2002-06-01       Impact factor: 7.396

5.  Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein.

Authors:  Seung Joon Baek; Jong-Sik Kim; Scott M Moore; Seong-Ho Lee; Jeanelle Martinez; Thomas E Eling
Journal:  Mol Pharmacol       Date:  2004-10-27       Impact factor: 4.436

6.  Scatter factor induces blood vessel formation in vivo.

Authors:  D S Grant; H K Kleinman; I D Goldberg; M M Bhargava; B J Nickoloff; J L Kinsella; P Polverini; E M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

7.  Egr-1-induced endothelial gene expression: a common theme in vascular injury.

Authors:  L M Khachigian; V Lindner; A J Williams; T Collins
Journal:  Science       Date:  1996-03-08       Impact factor: 47.728

8.  Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray.

Authors:  Sang Hwa Yang; Jong Sik Kim; Tae Jeong Oh; Myung Soon Kim; Sun Woo Lee; Suk Kyung Woo; Hyun Sill Cho; Yung Hyun Choi; Young Ho Kim; Sun Young Rha; Hyun Cheol Chung; Sung Whan An
Journal:  Int J Oncol       Date:  2003-04       Impact factor: 5.650

9.  Regulation of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MEK/ERK activation in human stomach cancer cell lines.

Authors:  Kyung Hee Lee; Eun Young Choi; Min Kyoung Kim; Myung Soo Hyun; Byung Ik Jang; Tae Nyeun Kim; Sang Woon Kim; Sun Kyo Song; Jung Hye Kim; Jae-Ryong Kim
Journal:  Exp Mol Med       Date:  2006-02-28       Impact factor: 8.718

10.  Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck.

Authors:  Simon Ninck; Christoph Reisser; Gerhard Dyckhoff; Burkhard Helmke; Harald Bauer; Christel Herold-Mende
Journal:  Int J Cancer       Date:  2003-08-10       Impact factor: 7.396

View more
  16 in total

1.  EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin.

Authors:  Joerg Kumbrink; Kathrin H Kirsch; Judith P Johnson
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

2.  A mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)-dependent transcriptional program controls activation of the early growth response 1 (EGR1) gene during amino acid limitation.

Authors:  Jixiu Shan; Mukundh N Balasubramanian; William Donelan; Lingchen Fu; Jaclyn Hayner; Maria-Cecilia Lopez; Henry V Baker; Michael S Kilberg
Journal:  J Biol Chem       Date:  2014-07-15       Impact factor: 5.157

3.  Prognostic and predictive significance of plasma HGF and IL-8 in a phase III trial of chemoradiation with or without tirapazamine in locoregionally advanced head and neck cancer.

Authors:  Quynh-Thu Le; Richard Fisher; Kelly S Oliner; Richard J Young; Hongbin Cao; Christina Kong; Edward Graves; Rodney J Hicks; Grant A McArthur; Lester Peters; Brian O'Sullivan; Amato Giaccia; Danny Rischin
Journal:  Clin Cancer Res       Date:  2012-03-01       Impact factor: 12.531

4.  Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinoma.

Authors:  Shan Ke; Xue-mei Ding; Jian Kong; Jun Gao; Shao-hong Wang; Yan Cheng; Wen-bing Sun
Journal:  J Transl Med       Date:  2010-07-29       Impact factor: 5.531

5.  Decidualization of Human Endometrial Stromal Fibroblasts is a Multiphasic Process Involving Distinct Transcriptional Programs.

Authors:  Kalle T Rytkönen; Eric M Erkenbrack; Matti Poutanen; Laura L Elo; Mihaela Pavlicev; Günter P Wagner
Journal:  Reprod Sci       Date:  2018-10-11       Impact factor: 3.060

6.  Coordinated sumoylation and ubiquitination modulate EGF induced EGR1 expression and stability.

Authors:  Arcangela Gabriella Manente; Giulia Pinton; Daniela Tavian; Gerardo Lopez-Rodas; Elisa Brunelli; Laura Moro
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

7.  Staphylococcus aureus Biofilm and Planktonic cultures differentially impact gene expression, mapk phosphorylation, and cytokine production in human keratinocytes.

Authors:  Patrick R Secor; Garth A James; Philip Fleckman; John E Olerud; Kate McInnerney; Philip S Stewart
Journal:  BMC Microbiol       Date:  2011-06-21       Impact factor: 3.605

8.  Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axis.

Authors:  D Lu; C Han; T Wu
Journal:  Oncogene       Date:  2011-07-11       Impact factor: 9.867

9.  Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1.

Authors:  Evin Ozen; Aysim Gozukizil; Esra Erdal; Aykut Uren; Donald P Bottaro; Nese Atabey
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

10.  Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site.

Authors:  Kurtis Eisermann; Carly J Broderick; Anton Bazarov; Mustafa M Moazam; Gail C Fraizer
Journal:  Mol Cancer       Date:  2013-02-01       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.